• 1
    Grabher C, Von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6: 34759.
  • 2
    Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107: 222333.
  • 3
    Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol 2000; 228: 15165.
  • 4
    Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004; 11: 42633.
  • 5
    Lee SY, Kumano K, Nakazaki K et al. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma. Cancer Sci 2009; 100: 9206.
  • 6
    Pear WS, Aster JC, Scott ML et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183: 228391.
  • 7
    Weng AP, Ferrando AA, Lee W et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 26971.
  • 8
    Lee SY, Kumano K, Masuda S et al. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 2005; 19: 18413.
  • 9
    Dumortier A, Jeannet R, Kirstetter P et al. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 2006; 26: 20920.
  • 10
    Lin YW, Nichols RA, Letterio JJ, Aplan PD. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood 2006; 107: 25403.
  • 11
    O’Neil J, Calvo J, McKenna K et al. Activating Notch1 mutations in mouse models of T-ALL. Blood 2006; 107: 7815.
  • 12
    Reschly EJ, Spaulding C, Vilimas T et al. Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood 2006; 107: 411521.
  • 13
    Weng AP, Nam Y, Wolfe MS et al. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol 2003; 23: 65564.
  • 14
    Lewis HD, Leveridge M, Strack PR et al. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of Notch signaling. Chem Biol 2007; 14: 20919.
  • 15
    O’Neil J, Grim J, Strack P et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors. J Exp Med 2007; 204: 181324.
  • 16
    Shih IeM, Wang TL. Notch signaling, γ-secretase inhibitors, and cancer therapy. Cancer Res 2007; 67: 187982.
  • 17
    Fuwa H, Okamura Y, Morohashi Y et al. Highly efficient synthesis of medium-sized lactams via intramolecular Staudingeraza-Wittig reaction of w-azido pentafluorophenyl ester: synthesis and biological evaluation of Ly411575 analogues. Tetrahedron Lett 2004; 45: 23236.
  • 18
    Kumano K, Masuda S, Sata M et al. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. Pigment Cell Melanoma Res 2008; 21: 708.
  • 19
    Wong GT, Manfra D, Poulet FM et al. Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 2004; 279: 1287682.
  • 20
    Kumano K, Chiba S, Kunisato A et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003; 18: 699711.
  • 21
    Kitamura T, Koshino Y, Shibata F et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003; 31: 100714.
  • 22
    Masuda S, Kumano K, Shimizu K et al. Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci 2005; 96: 27482.
  • 23
    Noguera-Troise I, Daly C, Papadopoulos NJ et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006; 444: 10327.
  • 24
    Ridgway J, Zhang G, Wu Y et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444: 10837.
  • 25
    Hellstrom M, Phng LK, Hofmann JJ et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445: 77680.
  • 26
    Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007; 445: 7814.
  • 27
    Yamanda S, Ebihara S, Asada M et al. Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. Blood 2009; 113: 36319.
  • 28
    Real PJ, Tosello V, Palomero T et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 2009; 15: 508.
  • 29
    Radtke F, Wilson A, Stark G et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10: 54758.
  • 30
    Saito T, Chiba S, Ichikawa M et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 2003; 18: 67585.
  • 31
    Aster JC. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol 2005; 82: 295301.
  • 32
    Palomero T, Sulis ML, Cortina M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 120310.